HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross-sectional study in the Democratic Republic of Congo

Natalia Zotova, Itziar Familiar, Bienvenu Kawende, Fidele Lumande Kasindi, Noro Ravelomanana, Angela M Parcesepe, Adebola Adedimeji, Kathryn E Lancaster, Didine Kaba, Pélagie Babakazo, Marcel Yotebieng, Natalia Zotova, Itziar Familiar, Bienvenu Kawende, Fidele Lumande Kasindi, Noro Ravelomanana, Angela M Parcesepe, Adebola Adedimeji, Kathryn E Lancaster, Didine Kaba, Pélagie Babakazo, Marcel Yotebieng

Abstract

Introduction: Disclosure of one's HIV status may decrease depression and improve the quality of life among people living with HIV. However, there is mixed evidence on the impact of disclosure to partners for pregnant women living with HIV (WLHIV) in areas of intersecting social concerns over disclosure and high prevalence of intimate partner violence (IPV). We assessed the association between HIV disclosure and depressive symptoms among pregnant WLHIV in the Democratic Republic of Congo (DRC) and examined whether the knowledge of partner's status or recent IPV modified this association.

Methods: We utilized data from participants enrolled in a trial to evaluate the effect of continuous quality interventions on long-term therapy outcomes among HIV-positive pregnant and breastfeeding women in DRC (NCT03048669). Only pregnant women (n = 1392) were included in this cross-sectional analysis. Between November 2016 and June 2019, enrolled participants completed a survey that included the Patient Health Questionnaire-9 (PHQ-9) to screen recent depressive symptoms, questions about disclosure, knowledge of partner's status and IPV. We used linear models to calculate crude and adjusted mean differences (MDs) between disclosure and depressive symptoms. All analyses were stratified by timing of HIV diagnosis.

Results: Disclosure was higher among participants diagnosed prior to current pregnancy (41% to their partners and 24% to family, friends or others) relative to those diagnosed during current pregnancy (21% to partners and 12% to family). About one-quarter of women reported any type of IPV in the past 12 months. Disclosure to a partner was associated with lower depressive symptoms among women diagnosed prior to current pregnancy (MD -0.55; 95% CI: -1.06, -0.04) but the opposite was observed among those diagnosed during current pregnancy (MD 0.5; 95% CI: -0.4, 1.4). Adjustment for IPV, knowledge of partner's status, age, number of living children and primigravidae did not change MDs substantially.

Conclusions: Women in our sample mostly disclosed to partners despite high IPV burden. The observed association between disclosure to partners and lower depressive symptoms among women diagnosed prior to current pregnancy is consistent with cross-national evidence. A prospective study among pregnant WLHIV is needed to examine longitudinal effects of HIV status disclosure.

Keywords: DR Congo; HIV; depression; intimate partner violence; pregnant women; status disclosure.

Conflict of interest statement

The authors have no competing of interests to declare.

© 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Figures

Figure 1
Figure 1
Participants’ inclusion flowchart.

References

    1. Remien RH, Stirratt MJ, Nguyen N, Robbins RN, Pala AN, Mellins CA. Mental health and HIV/AIDS: the need for an integrated response. AIDS. 2019;. 33(9):1411–20.
    1. Ngocho JS, Watt MH, Minja L, Knettel BA, Mmbaga BT, Williams PP, et al. Depression and anxiety among pregnant women living with HIV in Kilimanjaro region, Tanzania. PLoS One. 2019;. 14(10):e0224515.
    1. Sowa NA, Cholera R, Pence BW, Gaynes BN. Perinatal depression in HIV‐infected African women: a systematic review. J Clin Psychiatry. 2015;. 76(10):1385–96.
    1. Ezeamama AE, Woolfork MN, Guwatudde D, Bagenda D, Manabe YC, Fawzi WW, et al. Depressive and anxiety symptoms predict sustained quality of life deficits in HIV‐positive Ugandan adults despite antiretroviral therapy: a prospective cohort study. Medicine. 2016;. 95(9):e2525.
    1. Pence BW, Mills JC, Bengtson AM, Gaynes BN, Breger TL, Cook RL, et al. Association of increased chronicity of depression with HIV appointment attendance, treatment failure, and mortality among HIV‐infected adults in the United States. JAMA Psychiatry. 2018;. 75(4):379–85.
    1. Yousuf A, Mohd Arifin SR, Musa R, Md Isa ML. Depression and HIV disease progression: a mini‐review. Clin Pract Epidemiol Ment Health. 2019;. 15:153–59.
    1. Deshmukh NN, Borkar AM, Deshmukh JS. Depression and its associated factors among people living with HIV/AIDS: can it affect their quality of life? J Family Med Prim Care. 2017;. 6(3):549–53.
    1. Regan M, Muhihi A, Nagu T, Aboud S, Ulenga N, Kaaya S, et al. Depression and viral suppression among adults living with HIV in Tanzania. AIDS Behav. 2021;. 25(10):3097–105.
    1. Peltzer K, Rodriguez VJ, Jones D. Prevalence of prenatal depression and associated factors among HIV‐positive women in primary care in Mpumalanga province, South Africa. SAHARA J. 2016;. 13(1):60–7.
    1. Waldron EM, Burnett‐Zeigler I, Wee V, Ng YW, Koenig LJ, Pederson AB, et al. Mental health in women living with HIV: the unique and unmet needs. J Int Assoc Provid AIDS Care. 2021;. 20:2325958220985665.
    1. Messer LC, Quinlivan EB, Adimora A, Roytburd K. Self‐reported depression and social support are associated with egocentric network characteristics of HIV‐infected women of color. BMC Womens Health. 2020;. 20(1):80.
    1. Brittain K, Mellins CA, Remien RH, Phillips T, Zerbe A, Abrams EJ, et al. HIV‐status disclosure and depression in the context of unintended pregnancy among South African women. Glob Public Health. 2019;. 14(8):1087–97.
    1. Kiene SM, Dove M, Wanyenze RK. Depressive symptoms, disclosure, HIV‐related stigma, and coping following HIV testing among outpatients in Uganda: a daily process analysis. AIDS Behav. 2018;. 22(5):1639–51.
    1. Abuogi L, Hampanda K, Odwar T, Helova A, Odeny T, Onono M, et al. HIV status disclosure patterns and male partner reactions among pregnant women with HIV on lifelong ART in Western Kenya. AIDS Care. 2020;. 32(7):858–68.
    1. Aloyce Z, Larson E, Komba A, Mwimba A, Kaale A, Minja A, et al. Prevalence and factors associated with intimate partner violence after HIV status disclosure among pregnant women with depression in Tanzania. AIDS Care. 2020;. 33(8):1009–15.
    1. LeMasters K, Dussault J, Barrington C, Bengtson A, Gaynes B, Go V, et al. “Pain in my heart”: understanding perinatal depression among women living with HIV in Malawi. PLoS One. 2020;. 15(6):e0227935.
    1. Nyamukoho E, Mangezi W, Marimbe B, Verhey R, Chibanda D. Depression among HIV positive pregnant women in Zimbabwe: a primary health care based cross‐sectional study. BMC Pregnancy Childbirth. 2019;. 19(1):53.
    1. Manongi R, Rogathi J, Sigalla G, Mushi D, Rasch V, Gammeltoft T, et al. The association between intimate partner violence and signs of depression during pregnancy in Kilimanjaro region, Northern Tanzania. J Interpers Violence. 2020;. 35(23–24):5797–811.
    1. Watt MH, Knippler ET, Knettel BA, Sikkema KJ, Ciya N, Myer L, et al. HIV disclosure among pregnant women initiating ART in Cape Town, South Africa: qualitative perspectives during the pregnancy and postpartum periods. AIDS Behav. 2018;. 22(12):3945–56.
    1. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;. 367(5):399–410.
    1. Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, et al. Uptake, engagement, and adherence to pre‐exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72‐week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020;. 7:e249–61.
    1. Sack DE, De Schacht C, Paulo P, Graves E, Emílio AM, Matino A, et al. Pre‐exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique. Glob Health Action. 2021;. 14(1):1940764.
    1. Yotebieng M, Mpody C, Ravelomanana NL, Tabala M, Malongo F, Kawende B, et al. HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI‐PMTCT study. J Int AIDS Soc. 2019;. 22(9):e25376.
    1. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self‐report version of PRIME‐MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;. 282(18):1737–44.
    1. Yotebieng KA, Fokong K, Yotebieng M. Depression, retention in care, and uptake of PMTCT service in Kinshasa, the Democratic Republic of Congo: a prospective cohort. AIDS Care. 2017;. 29(3):285–89.
    1. Gichane MW, Moracco KE, Thirumurthy H, Okitolonda EW, Behets F, Yotebieng M. Intimate partner violence and prevention of mother to child transmission of HIV: evidence from Kinshasa, Democratic Republic of Congo. PLoS One. 2018;. 13(8):e0203471.
    1. Garcia‐Moreno C, Jansen HA, Ellsberg M, Heise L, Watts CH. Prevalence of intimate partner violence: findings from the WHO multi‐country study on women's health and domestic violence. Lancet North Am Ed. 2006;. 368(9543):1260–9.
    1. McFarlane J, Parker B, Soeken K, Bullock L. Assessing for abuse during pregnancy: severity and frequency of injuries and associated entry into prenatal care. JAMA. 1992;. 267(23):3176–8.
    1. State and Local Youth Risk Behavior Survey [Internet]. Centers for Disease Control and Prevention; 2020. [updated 2020 Nov 17; cited 2021 Sept 28]; [21 screens]. Available from: .
    1. Familiar I, Murray S, Ruisenor‐Escudero H, Sikorskii A, Nakasujja N, Boivin MJ, et al. Socio‐demographic correlates of depression and anxiety among female caregivers living with HIV in rural Uganda. AIDS Care. 2016;. 28(12):1541–45.
    1. Yotebieng M, Thirumurthy H, Moracco KE, Kawende B, Chalachala JL, Wenzi LK, et al. Conditional cash transfers and uptake of and retention in prevention of mother‐to‐child HIV transmission care: a randomised controlled trial. Lancet HIV. 2016;. 3(2):e85–93.
    1. Cholera R, Gaynes BN, Pence BW, Bassett J, Qangule N, Macphail C, et al. Validity of the Patient Health Questionnaire‐9 to screen for depression in a high‐HIV burden primary healthcare clinic in Johannesburg, South Africa. J Affect Disord. 2014;. 167:160–6.
    1. Monahan PO, Shacham E, Reece M, Kroenke K, Ong'or WO, Omollo O, et al. Validity/reliability of PHQ‐9 and PHQ‐2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med. 2009;. 24(2):189–97.
    1. Pence BW, Gaynes BN, Atashili J, O'Donnell JK, Tayong G, Kats D, et al. Validity of an interviewer‐administered patient health questionnaire‐9 to screen for depression in HIV‐infected patients in Cameroon. J Affect Disord. 2012;. 143(1–3):208–13.
    1. Stockton MA, Gaynes BN, Hosseinipour MC, Pettifor AE, Maselko J, Mphonda SM, et al. Association between depression and HIV care engagement outcomes among patients newly initiating ART in Lilongwe, Malawi. AIDS Behav. 2021;. 25(3):826–35.
    1. StataCorp . Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC; 2019.
    1. Cederbaum JA, Rice E, Craddock J, Pimentel V, Beaver P. Social networks of HIV‐positive women and their association with social support and depression symptoms. Women Health. 2017;. 57(2):268–82.
    1. Liu C, Goparaju L, Barnett A, Wang C, Poppen P, Young M, et al. Change in patterns of HIV status disclosure in the HAART era and association of HIV status disclosure with depression level among women. AIDS Care. 2017;. 29(9):1112–18.
    1. Miller ES, Yee LM, Dorman RM, McGregor DV, Sutton SH, Garcia PM, et al. Is maternal disclosure of HIV serostatus associated with a reduced risk of postpartum depression? Am J Obstet Gynecol. 2016;215(4):521.e1‐5.
    1. Tam M, Amzel A, Phelps BR. Disclosure of HIV serostatus among pregnant and postpartum women in sub‐Saharan Africa: a systematic review. AIDS Care. 2015;. 27(4):436–50.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa